Eyes Irritation Relief

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
Eyes Irritation Relief
Generic name
POLYVINYL ALCOHOL AND POVIDONE AND TETRAHYDROZOLINE HYDROCHLORIDE
Manufacturer
CARDINAL HEALTH 110, LLC. DBA LEADER
Product type
HUMAN OTC DRUG
SPL set ID
bd2608c6-ffdf-352a-e053-2995a90a26a8
SPL ID
aaaabf8c-8ca5-4fe3-8e21-ba270c7f3991
Version
3
Effective date
2025-09-12
Source export date
2026-11-06
Source partition
7
Source file
https://download.open.fda.gov/drug/label/drug-label-0007-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-11-06/824fe785252d7061429a95ddb6de517ee399ef628d34e8fdcc3591ded286ae33/drug-label-0007-of-0014.json.zip
Source manifest SHA-256
4a7570ba105b5a039a8e1c94a85e7f085b9047a8882a35a96bf1e4516c5ffc97
Import run
20261108T063105Z
Imported at
2026-11-08 07:24:55
Harmonized routes table
Harmonized routes
OPHTHALMIC

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only Do not use if solution changes color or becomes cloudy. Ask a doctor before use if you have narrow angle glaucoma. When using this product ▪ to avoid contamination, do not touch tip to any surface ▪ replace cap after using ▪ overuse may produce increased redness of the eye ▪ pupils may become enlarged temporarily Stop use & ask a doctor if ▪ you experience eye pain ▪ you experience changes in vision ▪ you experience continued redness or irritation of the eye ▪ the condition worsens ▪ symptoms last for more than 72 hours Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center(1-800-222-1222) right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.